Fundz

McKesson Corporation

Irving, Texas, United States · Biotechnology, Health Care, Pharmaceutical

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable.

Key facts

Headquarters
Irving, Texas, United States
Employees
21,162
Industries
Biotechnology, Health Care, Pharmaceutical
Status
Public (MCK)
Website
www.mckesson.com
LinkedIn
Company page

Recent activity at McKesson Corporation

  • : McKesson Corporation Announces Acquisition of Option Care Health, Inc.
  • : SEC 8-K (7.01): On October 6, 2026, McKesson Corporation announced a proposed acquisition of Option Care Health, Inc., in collaboration with Clayton, Dubilier & Rice, LLC. The news release detailing this event signifies a significant business transaction for McKesson, enhancing its portfolio in the healthcare sector. The specifics about the financial terms or strategic implications of the acquisition were not disclosed in the report, but it emphasizes a move towards expanding healthcare services. The announcement was made public through a joint news release, which is accessible via McKesson's official website.
  • : McKesson Extends Pharmaceutical Distribution Partnership with CVS Health through June 2032.
  • : SEC 8-K (7.01): On August 25, 2026, McKesson Corporation disclosed a cybersecurity incident affecting its information systems. The investigation is at an early stage, and the company has not yet determined whether the incident is material or if it poses any significant impact on financial conditions or operations. Updates regarding the incident will be available on McKesson's cybersecurity dedicated webpage. This disclosure is part of the company's ongoing efforts to ensure transparency during the situation, although it is currently unclear if the event will lead to any material adverse effects.
  • : McKesson to acquire Precision Medicine Group for $2.25B
  • : SEC 8-K (5.02): On June 29, 2026, Thomas L. Rodgers, the company’s Executive Vice President, Chief Strategy and Business Development Officer, announced his retirement, with his last day of employment set for August 1, 2026. To facilitate a smooth transition, Ramesh Srinivasan has been appointed as the new Executive Vice President, Chief Strategy Officer, effective the same day, August 1, 2026. This change is significant as it reflects the company's strategic intent to maintain leadership stability during a critical transitional period. The adjustments in executive leadership could impact future business development strategies and operational efficiency.
  • : SEC 8-K (1.01): On June 9, 2026, McKesson Corporation's subsidiary, McKesson Medical-Surgical Top Holdings, Inc., entered into an amendment to the Credit Agreement to establish a $2,250 million senior secured term 'B' loan facility due in 2032. The amendment adjusts terms, maintaining previous conditions while adding a new borrowing option with interest rates influenced by the Adjusted Term SOFR Rate or Base Rate. Borrowing obligations are secured by a security interest in major assets of the Borrower and certain subsidiaries, under strict financial covenants including leverage and interest coverage ratios. This strategic financial move allows McKesson greater liquidity while potentially reducing financing costs.
  • : SEC 8-K (1.01):
  • : SEC 8-K (1.01):
  • : McKesson launches an expanded wound care portfolio focusing on B2B solutions to improve chronic wound management.

Leadership

  • Joe Murphy, Sr Software Engineer
  • Brian Mason, Account Executive
  • Renuka Pakanati, Senior Accountant
  • Kunwar Chowhan, Senior Software Engineer
  • Barbara E Clark, Customer Service Representative
  • Varaprasad Kotha, Lead Software Engineer
  • Naga Pratap, Lead Systems Engineer
  • Tine Richardson, PAC Account Manager
  • Alexa Hilt, Sr. Field Sales Representative-Home Infusion Therapy
  • Frank Fernandez, Hr Manager
  • Rushali Rodrigo, Shipper and Quality Clerk
  • Mike Stone, Senior Production Control Analyst/Programmer

Verified email and direct lines for McKesson Corporation’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Employee benefit plans

McKesson Corporation files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Mar 2027.

McKesson Corporation in the news

Companies similar to McKesson Corporation

About McKesson Corporation: questions and answers

What does McKesson Corporation do?

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable.

Where is McKesson Corporation headquartered?

McKesson Corporation is headquartered in Irving, Texas, United States.

How many employees does McKesson Corporation have?

McKesson Corporation has about 21,162 employees.

What is the latest news on McKesson Corporation?

On Oct 06, 2026, McKesson Corporation Announces Acquisition of Option Care Health, Inc.

Is McKesson Corporation a public company?

Yes. McKesson Corporation is publicly traded under the ticker MCK.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches McKesson Corporation across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.